Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4+ CD25+ Treg cells

Background. In a rat model (PVG.R8-to-PVG.1U) disparate for one class I antigen, RT.1A(a), we previously demonstrated that intrathymic immunomodulation with donor antigens resulted in prolonged survival of cardiac allografts that underwent chronic rejection. However, long-term survivors developed a regulatory cell population that prevented both acute and chronic rejection when adoptively transferred into secondary graft recipients. The purpose of this study wag to characterize these regulatory cells with particular emphasis on CD4(+)CD25(+) T-reg cells. Methods. Spleens, lymph nodes, and peripheral blood lymphocytes of secondary tolerant recipients were characterized using antibodies to various T cell markers in flow cytometry. In vitro MLR and in vivo adoptive transfer experiments were conducted to investigate the involvement of CD4(+)CD25(+) T cells in the observed tolerance. The presence of various cytokines in the sera of graft recipients and MLR culture supernatants was tested using ELISA. Results. Tolerant recipients compared with naive rats had substantially higher percentages of CD4(+)CD25(+) T cells in the spleen (28 +/- 3% vs. 11 +/- 5%) and blood (23 +/- 6% vs. 9 +/- 4%). Tolerant animals also had higher levels of serum IL-10 than naive and rejecting animals. CD4(+)CD25(+) T cells from secondary long-term graft survivors inhibited donor-specific proliferative responses in vitro that was associated with high IL-10 production. Importantly, depletion of CD4(+)CD25(+) T cells from splenocytes of tolerant rats abrogated their ability to transfer tolerance to tertiary graft recipients. Conclusions. Our data demonstrate that cardiac allograft tolerance in this model is mediated by CD4+CD25+ T-reg cells primed by indirect recognition and is associated with high levels of IL-10.